TACT 8-K
Transact Technologies Inc (TACT)
8-K
2021-11-09
For: 2021-11-09
View Original
Added on
April 06, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 9, 2021
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission file number) |
(I.R.S. employer identification no.) |
(Address of principal executive offices) |
(Zip Code) |
Registrant's telephone number, including area code: (203 ) 859-6800
(Former Name or Former Address, if Changed Since Last Report): Not applicable.
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
The following information is being furnished pursuant to Item 2.02 “Results of Operations and Financial Condition” of Form 8-K. Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
On November 9, 2021, TransAct Technologies Incorporated issued a press release announcing its financial results for the quarter ending September 30, 2021. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Press Release dated November 9, 2021 of TransAct Technologies Incorporated |
||
104 |
Cover page from this Current Report on Form 8-K, formatted in Inline XBRL |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TRANSACT TECHNOLOGIES INCORPORATED |
|||||
By: |
/s/ David B. Peters |
||||
David B. Peters |
|||||
Vice President & Chief Accounting Officer |
|||||
Date: November 9, 2021
Exhibit 99.1
TransAct Technologies Reports Preliminary Third Quarter 2021 Financial Results
2021 Third Quarter Net Sales of $10.6 Million
FST Recurring Revenue of $2.0 Million, up 28% on a Year-Over-Year Basis
FST Paid Terminals Up 129% from September 30, 2020
Hamden, CT – November 9, 2021 – TransAct
Technologies Incorporated (Nasdaq: TACT) (“TransAct” or the “Company”), a global leader in software-driven technology and printing solutions for high-growth markets, today reported preliminary operating results for the quarter ended September 30,
2021.
“Our results mark the highest quarterly net sales since the fourth quarter of 2019, due to sustained momentum in BOHA! and our key
Food Service Technology (“FST”) business, and a fantastic rebound in our domestic casino and gaming markets. We posted another quarter of over $2 million in recurring FST revenue, including gains in our high margin software and label recurring
revenues, even in the face of a then-surging Delta variant. We also saw some solid BOHA! terminal additions, and we ended the quarter at 8,749 paid terminals in the market, representing over 3,000 added during the first nine months of 2021. Even
though we are only in the early stages of our BOHA! growth story, we are already seeing the power of our recurring revenue base beginning to drive consistent results. We are also experiencing continued strong interest in our BOHA! solution to help
with the labor shortages faced by our FST customers,” said Bart C. Shuldman, Chairman and CEO of TransAct. “In addition, we are really pleased with the encouraging trends in the casino and gaming market, with sales up over 100% year-over-year to $4
million for the third quarter of 2021. The domestic rebound is leading the way, courtesy of the continued reinvestment in the casino floor, as the American gamer clearly has been very eager to return to business as usual.”
Third Quarter 2021 Financial Highlights
|
•
|
Net
Sales: Net sales for the third quarter of 2021 were $10.6 million, up 46% compared to $7.3 million for the third quarter of 2020.
|
|
•
|
FST
Recurring Revenue: FST recurring revenue for the third quarter of 2021 was $2.0 million, up 28% compared to $1.6 million for the third quarter of 2020.
|
|
•
|
Gross
Profit: Gross profit for the third quarter of 2021 was $4.3 million, resulting in gross margin of 40.6%, compared to gross profit of $3.3 million for the third quarter of 2020, which resulted in a 45.9% gross margin.
|
|
•
|
Operating
loss: Operating loss for the third quarter of 2021 was $(1.6) million, compared to operating loss of $(1.5) million for the third quarter of 2020.
|
|
•
|
Net
income (loss): Net income for the third quarter of 2021 was $0.9 million, or $0.09 per share, based on 9.8 million weighted average common shares outstanding. Net loss for the comparable 2020 period was $(0.9) million, or $(0.11)
net loss per diluted share, based on 7.5 million weighted average common shares outstanding.
|
|
•
|
Adjusted
net income (loss): Adjusted net loss for the third quarter of 2021 was $(1.3) million, or $(0.13) net loss per share compared to adjusted net loss for the third quarter of 2020 of $(0.9) million, or $(0.11) net loss per share.
|
|
•
|
EBITDA:
EBITDA was $0.7 million for the third quarter of 2021, compared to an EBITDA loss of $(1.1) million for the third quarter of 2020.
|
|
•
|
Adjusted
EBITDA loss: Adjusted EBITDA loss was $(1.2) million for the third quarter of 2021, compared to adjusted EBITDA loss of $(0.9) million for the third quarter of 2020.
|
|
•
|
Paid Terminals: Paid terminals in the market were 8,749 on September 30, 2021, compared to 3,813 on September 30, 2020, an increase of 129%.
|
2021 Third Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today, November 9, 2021, beginning at 4:30 p.m. ET to discuss the Company’s
preliminary third quarter 2021 results and other matters. Both the call and the webcast are open to the general public. The conference call number is 856-344-9290 and the conference ID number is 8161388 (domestic or international). Please call five
minutes prior to the presentation to ensure that you are connected.
Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “Investor Relations”
followed by “Events & Presentations”). Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.
Non-GAAP Financial Measures
TransAct is providing certain non-GAAP financial measures because the Company believes that these measures are helpful to investors
and others in assessing the ongoing nature of what the Company’s management views as TransAct’s core operations. EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and
financing charges and income taxes. The Company believes that these non-GAAP financial measures provide relevant and useful information to an investor evaluating the Company’s operating performance because these measures are: (i) widely used by
investors to measure a company’s operating performance without regard to items that do not reflect the ordinary earnings from operations excluded from the calculation of such measure; (ii) used as financial measurements by lenders and other parties
to evaluate creditworthiness; and (iii) used by the Company’s management for various purposes including strategic planning and forecasting and assessing financial performance. Adjusted net income (loss) and adjusted net income (loss) per diluted
share provide the Company with an understanding of the results of the primary operations of the business by excluding the effects of special items (for example, the forgiveness of the Company’s $2.2 million loan under the Paycheck Protection Program
(the “PPP Loan”) administered by the Small Business Administration (the “SBA”) pursuant to the Coronavirus Aid, Relief, and Economic Security Act of 2020 (the “CARES Act”), that do not reflect the ordinary earnings of the Company’s operations. The
Company uses these measures to evaluate period-over-period operating performance because the Company believes this provides a more comparable measure of the Company’s continuing business, as these measures adjust for special items that are not
reflective of the normal results of the business. These measures may be useful to an investor in evaluating the underlying operating performance of the Company’s business. The presentation of this non-GAAP information is not considered superior to
or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.
EBITDA is defined as net income (loss) before net interest expense, income taxes, depreciation and amortization. A reconciliation of
EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.
Adjusted EBITDA is defined as net income (loss) before net interest expense, income taxes, depreciation and amortization and is
adjusted for share-based compensation and the impact of the forgiveness of the PPP Loan by the SBA pursuant to the CARES Act. The Company adjusts EBITDA for share-based compensation because the Company considers share-based compensation to be a
non-cash expense similar to depreciation and amortization, and the Company adjusts for the impact of the PPP Loan forgiveness because the Company does not believe that this impact reflects ordinary earnings of the Company from operations. A
reconciliation of adjusted EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.
Adjusted net income (loss) is defined as net income (loss) adjusted for the impact of the forgiveness of the PPP Loan by the SBA
pursuant to the CARES Act. A reconciliation of adjusted net income (loss) to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.
Adjusted net income (loss) per diluted share is defined as adjusted net income (loss) divided by diluted shares outstanding. A
reconciliation of adjusted net income (loss) per diluted share to net income (loss) per diluted share, the most comparable GAAP financial measure, can be found attached to this release.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a global leader in developing software-driven technology and printing solutions for high-growth
markets including food service, casino and gaming, POS automation, and oil and gas. The Company’s solutions are designed from the ground up based on customer requirements and are sold under the BOHA! ™, AccuDate™, EPICENTRAL®, Epic, Ithaca® and
Printrex® brands. TransAct has sold over 3.6 million printers, terminals and other hardware devices around the world and is committed to providing world-class service, spare parts and accessories to support its installed product base. Through the
TransAct Services Group, the Company also provides customers with a complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in Hamden, CT. For more
information, please visit http://www.transact-tech.com or call (203) 859-6800.
TransAct®, BOHA!™, AccuDate™, Epic, EPICENTRAL®, Ithaca® and Printrex® are trademarks of TransAct Technologies Incorporated. ©2021
TRANSACT Technologies Incorporated. All rights reserved.
Cautionary Statement Regarding Preliminary Financial Information
The Company has prepared the preliminary financial information set forth below on a materially consistent basis with its historical
financial information and in good faith based upon its internal reporting as of and for the three and nine months ended September 30, 2021. This financial information is preliminary and is thus inherently uncertain and subject to change as the
Company finalizes its financial results and related review for the three and nine months ended September 30, 2021. During the course of the preparation of the Company’s consolidated financial statements and related notes as of and for the three and
nine months ended September 30, 2021, the Company may identify items that could cause its final reported results to be materially different from the preliminary financial information set forth above. As a result, there can be no assurance that the
Company’s final results for this period will not differ from the preliminary financial information.
This preliminary financial information should not be viewed as a substitute for full financial statements prepared in accordance with
GAAP. In addition, this preliminary financial information is not necessarily indicative of the results to be achieved for any future period.
Forward-Looking Statements
Certain statements in this press release include forward-looking statements. Forward-looking statements generally can be identified
by the use of forward-looking terminology, such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe", or "continue", or the negative thereof, or other similar words. All forward-looking statements involve risks and uncertainties,
including, but not limited to, the adverse effects of the COVID-19 pandemic, related vaccination rates and the emergence of virus variants on our business, operations, financial condition, results of operations and capital resources, including as a
result of supply chain disruptions, shutdowns and/or operational restrictions imposed on our customers, an inability of our customers to make payments on time or at all, diversion of management attention, necessary modifications to our business
practices and operations, cost cutting measures we have made and may continue to make, a possible future reduction in the value of goodwill or other intangible assets, inadequate manufacturing capacity or a shortfall or excess of inventory as a
result of difficulty in predicting manufacturing requirements due to volatile economic conditions, price increases or decreased availability of component parts or raw materials, exchange rate fluctuations, volatility of and decreases in trading
prices of our common stock and the availability of needed financing on acceptable terms or at all; our ability to successfully develop new products that garner customer acceptance and generate sales, both domestically and internationally, in the face
of substantial competition; our reliance on an unrelated third party to develop, maintain and host certain web-based food service application software and develop and maintain selected components of our downloadable software applications pursuant to
a non-exclusive license agreement, and the risk that interruptions in our relationship with that third party could materially impair our ability to provide services to our food service technology customers on a timely basis or at all and could
require substantial expenditures to find or develop alternative software products; our ability to successfully transition our business into the food service technology market; our ability to fully remediate a previously disclosed material weakness
over internal control over financial reporting; risks associated with potential future acquisitions; general economic conditions; our dependence on contract manufacturers for the assembly of a large portion of our products in Asia; our dependence on
significant suppliers; our ability to recruit and retain quality employees as the Company grows; our dependence on third parties for sales outside the United States; our dependence on technology licenses from third parties; marketplace acceptance of
new products; risks associated with foreign operations; the availability of third-party components at reasonable prices; price wars or other significant pricing pressures affecting the Company's products in the United States or abroad; increased
product costs or reduced customer demand for our products due to changes in U.S. policy that may result in trade wars or tariffs; our ability to protect intellectual property; the effect of the United Kingdom’s withdrawal from the European Union; and
other risk factors detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and other reports filed with the Securities and Exchange Commission. Actual results may differ materially from those discussed in, or
implied by, the forward-looking statements. The forward-looking statements speak only as of the date of this release, and the Company assumes no duty to update them to reflect new, changing or unanticipated events or circumstances, except as required
by applicable law.
# # #
Investor Contact:
|
Bart Shuldman
Chairman and Chief Executive Officer
TransAct Technologies Incorporated
|
Ryan Gardella
ICR, Inc.
|
- Financial tables follow –
|
TRANSACT TECHNOLOGIES INCORPORATED
|
||||||||||||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||||||||||
|
(Preliminary and Unaudited)
|
||||||||||||||||
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
|
September 30,
|
September 30,
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
(In thousands, except per share data)
|
||||||||||||||||
|
Net sales
|
$
|
10,637
|
$
|
7,300
|
$
|
28,263
|
$
|
22,832
|
||||||||
|
Cost of sales
|
6,320
|
3,951
|
17,432
|
12,275
|
||||||||||||
|
Gross profit
|
4,317
|
3,349
|
10,831
|
10,557
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Engineering, design and product development
|
1,876
|
1,445
|
5,483
|
4,197
|
||||||||||||
|
Selling and marketing
|
1,899
|
1,258
|
5,109
|
4,885
|
||||||||||||
|
General and administrative
|
2,146
|
2,125
|
7,264
|
6,987
|
||||||||||||
|
5,921
|
4,828
|
17,856
|
16,069
|
|||||||||||||
|
Operating loss
|
(1,604
|
)
|
(1,479
|
)
|
(7,025
|
)
|
(5,512
|
)
|
||||||||
|
Interest and other income (expense):
|
||||||||||||||||
|
Interest, net
|
(29
|
)
|
(19
|
)
|
(71
|
)
|
(41
|
)
|
||||||||
|
Other, net
|
2,104
|
116
|
2,004
|
(60
|
)
|
|||||||||||
|
2,075
|
97
|
1,933
|
(101
|
)
|
||||||||||||
|
Income (loss) before income taxes
|
471
|
(1,382
|
)
|
(5,092
|
)
|
(5,613
|
)
|
|||||||||
|
Income tax benefit
|
439
|
515
|
1,682
|
1,901
|
||||||||||||
|
Net income (loss)
|
$
|
910
|
$
|
(867
|
)
|
$
|
(3,410
|
)
|
$
|
(3,712
|
)
|
|||||
|
Net income (loss) per common share:
|
||||||||||||||||
|
Basic
|
$
|
0.10
|
$
|
(0.11
|
)
|
$
|
(0.37
|
)
|
$
|
(0.49
|
)
|
|||||
|
Diluted
|
$
|
0.09
|
$
|
(0.11
|
)
|
$
|
(0.37
|
)
|
$
|
(0.49
|
)
|
|||||
|
Shares used in per share calculation:
|
||||||||||||||||
|
Basic
|
9,408
|
7,548
|
9,112
|
7,533
|
||||||||||||
|
Diluted
|
9,846
|
7,548
|
9,112
|
7,533
|
||||||||||||
|
SUPPLEMENTAL INFORMATION – SALES BY MARKET:
(Preliminary and Unaudited)
|
||||||||||||||||
|
Three months ended
|
Nine months ended
|
|||||||||||||||
|
September 30,
|
September 30,
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Food service technology
|
$
|
3,282
|
$
|
2,349
|
$
|
9,103
|
$
|
4,924
|
||||||||
|
POS automation
|
1,188
|
742
|
3,608
|
2,781
|
||||||||||||
|
Casino and gaming
|
4,036
|
2,009
|
10,368
|
8,300
|
||||||||||||
|
Lottery
|
-
|
-
|
-
|
817
|
||||||||||||
|
Printrex
|
160
|
107
|
431
|
232
|
||||||||||||
|
TransAct Services Group
|
1,971
|
2,093
|
4,753
|
5,778
|
||||||||||||
|
Total net sales
|
$
|
10,637
|
$
|
7,300
|
$
|
28,263
|
$
|
22,832
|
||||||||
|
TRANSACT TECHNOLOGIES INCORPORATED
|
||||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS
|
||||||||
|
(Preliminary and Unaudited)
|
||||||||
|
September 30,
|
December 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
(In thousands)
|
||||||||
|
Assets:
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
18,658
|
$
|
10,359
|
||||
|
Accounts receivable, net
|
6,501
|
3,377
|
||||||
|
Note receivable
|
-
|
100
|
||||||
|
Inventories
|
6,369
|
11,286
|
||||||
|
Prepaid income taxes
|
2,519
|
2,409
|
||||||
|
Other current assets
|
1,182
|
644
|
||||||
|
Total current assets
|
35,229
|
28,175
|
||||||
|
Fixed assets, net
|
2,332
|
1,950
|
||||||
|
Note receivable, net of current portion
|
-
|
1,584
|
||||||
|
Right-of-use asset
|
2,750
|
3,618
|
||||||
|
Goodwill
|
2,621
|
2,621
|
||||||
|
Deferred tax assets
|
4,506
|
2,939
|
||||||
|
Intangible assets, net
|
435
|
583
|
||||||
|
Other assets
|
476
|
777
|
||||||
|
13,120
|
14,072
|
|||||||
|
Total assets
|
$
|
48,349
|
$
|
42,247
|
||||
|
Liabilities and Shareholders’ Equity:
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
1,676
|
$
|
1,691
|
||||
|
Accrued liabilities
|
3,511
|
3,665
|
||||||
|
Lease liability
|
816
|
837
|
||||||
|
Deferred revenue
|
768
|
504
|
||||||
|
Total current liabilities
|
6,771
|
6,697
|
||||||
|
Long-term debt
|
-
|
2,173
|
||||||
|
Deferred revenue, net of current portion
|
207
|
111
|
||||||
|
Lease liability, net of current portion
|
1,956
|
2,864
|
||||||
|
Other liabilities
|
135
|
166
|
||||||
|
2,298
|
5,314
|
|||||||
|
Total liabilities
|
9,069
|
12,011
|
||||||
|
Shareholders’ equity:
|
||||||||
|
Common stock
|
139
|
130
|
||||||
|
Additional paid-in capital
|
54,873
|
42,536
|
||||||
|
Retained earnings
|
16,308
|
19,718
|
||||||
|
Accumulated other comprehensive income (loss), net of tax
|
70
|
(38
|
)
|
|||||
|
Treasury stock, at cost
|
(32,110
|
)
|
(32,110
|
)
|
||||
|
Total shareholders’ equity
|
39,280
|
30,236
|
||||||
|
Total liabilities and shareholders’ equity
|
$
|
48,349
|
$
|
42,247
|
||||
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
NON-GAAP FINANCIAL MEASURES
|
|
(Preliminary and Unaudited, thousands of dollars, except percentages and per share
amounts)
|
|
Three months ended
September 30, 2021
|
||||||||||||
|
Reported
|
Adjustments(1)
|
Adjusted
Non-GAAP
|
||||||||||
|
Operating expenses
|
$
|
5,921
|
$
|
-
|
$
|
5,921
|
||||||
|
% of net sales
|
55.7
|
%
|
55.7
|
%
|
||||||||
|
Operating loss
|
(1,604
|
)
|
-
|
(1,604
|
)
|
|||||||
|
% of net sales
|
(15.1
|
)%
|
(15.1
|
)%
|
||||||||
|
Interest and other income (expense)
|
2,075
|
(2,173
|
)
|
(98
|
)
|
|||||||
|
Income (loss) before income taxes
|
471
|
(2,173
|
)
|
(1,702
|
)
|
|||||||
|
Income tax benefit
|
439
|
-
|
439
|
|||||||||
|
Net income (loss)
|
910
|
(2,173
|
)
|
(1,263
|
)
|
|||||||
|
Net income (loss) per common share:
|
||||||||||||
|
Basic
|
$
|
0.10
|
$
|
(0.23
|
)
|
$
|
(0.13
|
)
|
||||
|
Diluted
|
$
|
0.09
|
$
|
(0.22
|
)
|
$
|
(0.13
|
)
|
||||
|
Three months ended
September 30, 2020
|
||||||||||||
|
Reported
|
Adjustments(2)
|
Adjusted
Non-GAAP
|
||||||||||
|
Operating expenses
|
$
|
4,828
|
$
|
-
|
$
|
4,828
|
||||||
|
% of net sales
|
66.1
|
%
|
66.1
|
%
|
||||||||
|
Operating loss
|
(1,479
|
)
|
-
|
(1,479
|
)
|
|||||||
|
% of net sales
|
(20.3
|
)%
|
(20.3
|
)%
|
||||||||
|
Interest and other income
|
97
|
-
|
97
|
|||||||||
|
Loss before income taxes
|
(1,382
|
)
|
-
|
(1,382
|
)
|
|||||||
|
Income tax benefit
|
515
|
-
|
515
|
|||||||||
|
Net loss
|
(867
|
)
|
-
|
(867
|
)
|
|||||||
|
Net loss per common share:
|
||||||||||||
|
Basic
|
$
|
(0.11
|
)
|
-
|
$
|
(0.11
|
)
|
|||||
|
Diluted
|
$
|
(0.11
|
)
|
-
|
$
|
(0.11
|
)
|
|||||
|
(2)
|
No adjustments.
|
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
NON-GAAP FINANCIAL MEASURES
|
|
(Preliminary and Unaudited, thousands of dollars, except percentages and per share
amounts)
|
|
Nine months ended
September 30, 2021
|
||||||||||||
|
Reported
|
Adjustments(3)
|
Adjusted
Non-GAAP
|
||||||||||
|
Operating expenses
|
$
|
17,856
|
$
|
-
|
$
|
17,856
|
||||||
|
% of net sales
|
63.2
|
%
|
63.2
|
%
|
||||||||
|
Operating loss
|
(7,025
|
)
|
-
|
(7,025
|
)
|
|||||||
|
% of net sales
|
(24.9
|
)%
|
(24.9
|
)%
|
||||||||
|
Interest and other income (expense)
|
1,933
|
(2,173
|
)
|
(240
|
)
|
|||||||
|
Loss before income taxes
|
(5,092
|
)
|
(2,173
|
)
|
(7,265
|
)
|
||||||
|
Income tax benefit
|
1,682
|
-
|
1,682
|
|||||||||
|
Net loss
|
(3,410
|
)
|
(2,173
|
)
|
(5,583
|
)
|
||||||
|
Net loss per common share:
|
||||||||||||
|
Basic
|
$
|
(0.37
|
)
|
$
|
(0.24
|
)
|
$
|
(0.61
|
)
|
|||
|
Diluted
|
$
|
(0.37
|
)
|
$
|
(0.24
|
)
|
$
|
(0.61
|
)
|
|||
|
(3)
|
Adjustment includes $2,173 gain on forgiveness of the PPP Loan that occurred in July 2021.
|
|
Nine months ended
September 30, 2020
|
||||||||||||
|
Reported
|
Adjustments(4)
|
Adjusted
Non-GAAP
|
||||||||||
|
Operating expenses
|
$
|
16,069
|
$
|
-
|
$
|
16,069
|
||||||
|
% of net sales
|
70.4
|
%
|
70.4
|
%
|
||||||||
|
Operating loss
|
(5,512
|
)
|
-
|
(5,512
|
)
|
|||||||
|
% of net sales
|
(24.1
|
)%
|
(24.1
|
)%
|
||||||||
|
Interest and other expense
|
(101
|
)
|
-
|
(101
|
)
|
|||||||
|
Loss before income taxes
|
(5,613
|
)
|
-
|
(5,613
|
)
|
|||||||
|
Income tax benefit
|
1,901
|
-
|
1,901
|
|||||||||
|
Net loss
|
(3,712
|
)
|
-
|
(3,712
|
)
|
|||||||
|
$
|
(0.49
|
)
|
-
|
$
|
(0.49
|
)
|
||||||
|
Diluted
|
$
|
(0.49
|
)
|
-
|
$
|
(0.49
|
)
|
|||||
|
(4)
|
No adjustments.
|
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF NET INCOME (LOSS) TO EBITDA AND ADJUSTED EBITDA
NON-GAAP FINANCIAL MEASURES
|
|
(Preliminary and Unaudited)
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
|
September 30,
|
September 30,
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Net income (loss)
|
$
|
910
|
$
|
(867
|
)
|
$
|
(3,410
|
)
|
$
|
(3,712
|
)
|
|||||
|
Interest expense, net
|
29
|
19
|
71
|
41
|
||||||||||||
|
Income tax benefit
|
(439
|
)
|
(515
|
)
|
(1,682
|
)
|
(1,901
|
)
|
||||||||
|
Depreciation and amortization
|
235
|
263
|
721
|
758
|
||||||||||||
|
EBITDA
|
735
|
(1,100
|
)
|
(4,300
|
)
|
(4,814
|
)
|
|||||||||
|
Share-based compensation expense
|
257
|
231
|
952
|
644
|
||||||||||||
|
Forgiveness of the PPP Loan
|
(2,173
|
)
|
-
|
(2,173
|
)
|
-
|
||||||||||
|
Adjusted EBITDA
|
$
|
(1,181
|
)
|
$
|
(869
|
)
|
$
|
(5,521
|
)
|
$
|
(4,170
|
)
|
||||